Skip to main content
Caplight Logo









Vytruve

Vytruve

Private
FranceHealthcare & Life Scienceshttps://www.vytruve.com/

Last Round

Seed

Feb 19, 2024

Total Funding Raised

$3.28M

Company Overview

Vytruve is a medical technology company that provides an end-to-end 3D digital workflow for the design and manufacturing of prosthetic sockets.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, 3D Printing, Vertical SaaS, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Hardware Sales, Freemium

AI Layer

Non-AI

Keywords

prosthetic sockets3D printing3D scanningorthotics and prostheticsO&Pdigital workflowprosthetic designdigital rectificationadditive manufacturingvertical SaaSmedical devicesclinical softwarecheck socketsmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vytruve Comparables

Compare Vytruve with similar companies based on industry and business-model similarity.

Vytruve comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ProsFit
89%
Mecuris
84%
Invent Medical Group
80%

Vytruve Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 19, 2024
SeedJul 8, 2021

Key People

Founding team and executive leadership

Erwan CALVIER

CEO

Executive Team

Julien Maurat

Chief Technology Officer

Executive Team

Vytruve Investors

Notable investors and investment history

Vytruve investors
InvestorRounds
BpifranceSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2024

    $1.51M raised in Seed round.

  • Jul 8, 2021

    $1.77M round with Bpifrance

Vytruve Filings

Explore SEC and related filing metadata, where available.

Vytruve filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vytruve's valuation, stock price, and market status.

Is Vytruve a public or private company?

Vytruve is a private company.

What is the current stock price of Vytruve?

Vytruve is a private company with no public stock price. No recent secondary market data is available.

How much is Vytruve worth (valuation)?

Valuation information for Vytruve is not publicly available.

Can I buy Vytruve stock?

Vytruve shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vytruve's last funding round?

Vytruve's most recent funding round was Seed on February 19, 2024.

Who are the main investors in Vytruve?

Key investors in Vytruve include Bpifrance.

Will Vytruve IPO soon?

No public IPO plans have been announced for Vytruve.

How can I track Vytruve secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vytruve's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrance
Employee Range5
Year Founded2021
Last FundingFeb 19, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?